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The Progesterone Receptor – To Be or Not to Be: The Anti-Inflammatory
Effects of Progesterone in RAW 264.7 Cells
Abstract

It has been widely established that, in addition to its role in reproduction, progesterone (P4) also has potent
anti-inflammatory effects. While the precise mechanisms have never been clearly elucidated in RAW 246.7
cells, it seems logical to assume that this response is – at least in part - a consequence of activation of and
signaling through the progesterone receptor (P4-R). However, it has recently been shown that in a rat model,
this anti-inflammatory effect is – in fact - independent of the progesterone receptor. In this project, the aim
was to characterize this response by assaying nitric oxide production from lipopolysaccharide-challenged
RAW 264.7 cells and ascertain the involvement of the P4-R. To determine the contribution of the receptor,
RAW cells were incubated in the presence and absence of RU-486 – a potent P4-R antagonist. Our results
indicate that the anti-inflammatory response of progesterone was in fact through the activation of the P4-R as
cells incubated in RU-486 show an approximate 60% reversal of the inhibitory effect of P4 as compared to
cells incubated in the absence of the antagonist. However, because we did not observe a complete reversal,
suggests that perhaps other receptors come into play which will be addressed in future studies.
Creative Commons License

Creative
Commons
This work is licensed under a Creative Commons Attribution 4.0 License.
Attribution
4.0
License

This article is available in Proceedings of the Interdisciplinary STEM Teaching and Learning Conference:
https://digitalcommons.georgiasouthern.edu/stem_proceedings/vol1/iss1/8

Brandon and George: The Progesterone Receptor – To Be or Not to Be: The Anti-Inflamma
The Progesterone Receptor - To Be or Not to Be: The Anti-inflammatory
Effects of Progesterone in RAW 264.7 Cells
Christopher I Brandon Jr., Georgia Gwinnett College
Bagie M. George, Georgia Gwinnett College
Abstract: It has been widely established that, in addition to its role in
reproduction, progesterone (P4) also has potent anti-inflammatory effects. While
the precise mechanisms have never been clearly elucidated in RAW 246.7 cells, it
seems logical to assume that this response is – at least in part - a consequence of
activation of and signaling through the progesterone receptor (P4-R). However,
it has recently been shown that in a rat model, this anti-inflammatory effect
is – in fact - independent of the progesterone receptor. In this project, the aim
was to characterize this response by assaying nitric oxide production from
lipopolysaccharide-challenged RAW 264.7 cells and ascertain the involvement
of the P4-R. To determine the contribution of the receptor, RAW cells were
incubated in the presence and absence of RU-486 – a potent P4-R antagonist.
Our results indicate that the anti-inflammatory response of progesterone was
in fact through the activation of the P4-R as cells incubated in RU-486 show
an approximate 60% reversal of the inhibitory effect of P4 as compared to cells
incubated in the absence of the antagonist. However, because we did not observe
a complete reversal, suggests that perhaps other receptors come into play which
will be addressed in future studies.
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and analysis of data; The School of Science and Technology, Georgia Gwinnett
College for provision of facilities and equipment; and the University System of
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Introduction
Progesterone (P4) has long been known as a steroid hormone associated
with reproduction – more specifically in female reproductive physiology as it
is commonly referred to as the ‘hormone of pregnancy’ (King TL, 2010). Its
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presence is only observed in appreciable amounts during the luteal phase as
its source is the corpus luteum, and its primary role during this time period is
in endometrial remodeling as well as endometrial angiogenesis in preparation
for the arrival of an early embryo (Patel B, 2014). While this effect is critical for
the maintenance of pregnancy, just as important is the inhibitory role that P4
has – along with estrogen and inhibin – on the pituitary gonadotropins follicle
stimulating hormone (FSH) and luteinizing hormone (LH), respectively (Lesoon
LA, 1992). Secondary to these effects, P4 also plays a role as a mediator in many
inhibitory pathways such as: 1) modulation of maternal immune response and
suppression of key inflammatory mediators given that the luteal progesterone at
the decidua level appears to play a major role in the maternal defense strategy,
2) reduction of uterine contractility as adequate progesterone concentrations
in the myometrium plays an inhibitory role on prostaglandin and oxytocin’s
stimulatory activity, and 3) improvement of utero-placental circulation and luteal
phase support given that it has been shown that progesterone may promote the
invasion of extravillous trophoblasts to the decidua by inhibiting apoptosis of
extravillous trophoblasts (Di Renzo GC, 2016). Additionally, P4 is not without
its effects in the male in that it serves as precursor to testosterone, has a similar
inhibitory effect on the gonadotropins– albeit a weak effect – and is a precursor
to capacitation (Oettel M, 2004).
Given the steroid hormone chemistry of P4, it has widely been known
to signal through an intracellular receptor which is nuclear in origin – NR3C3,
that serves as a transcription factor driving the expression of many genes
associated with reproduction (Werner R, 2014). More recently however, a
membrane-bound receptor has also been identified which is a G protein-coupled
receptor, and has been isolated in many isoforms, namely mPR, mPR, mPR,
mPR, and mPR (Wolfson ML, 2016). The advent of signal transduction
mechanisms through these receptors have been shown to be primarily antiinflammatory in nature. However, in the study by Wolfson et al., it was reported
that the inhibition of at least one inflammatory mediator (nitric oxide – NO),
was through a progesterone independent mechanism. These authors went
on to suggest the possible involvement of the glucocorticoid receptors in this
immunomodulatory role. Regardless of the receptor involved or cell signaling
pathways initiated, the anti-inflammatory properties of progesterone are an
exciting avenue for scientific discovery and warrants exploration.
The Immune response is an immunological response that originates via
https://digitalcommons.georgiasouthern.edu/stem_proceedings/vol1/iss1/8
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activation by antigens, including the response to pathogenic microorganisms,
allergens, as well as autoimmunity to self-antigens, and graft ejections. It can
be further subdivided into the adaptive immune response involving T cells,
B lymphocytes, and the innate immune response involving the monocyte/
macrophage system, neutrophils, eosinophils, basophils as well as other tissues of
the lymphatic system. The monocyte/macrophage system is of particular interest
based on the many inflammatory mediators activated macrophages produce,
namely nitric oxide (NO) and tumor necrosis factor-alpha (TNF) because of
their integral role in the initiation of the inflammatory response. Nitric oxide
is a gas under standard conditions, is one of several oxides of nitrogen, and
is classified as a free radical. In mammals it is a potent vasodilator with short
half-life, and an important cell signaling molecule that is involved in many
physiological and pathological processes (Hou, 1999). It has been reported
that localized NO synthesis in reproductive tissue plays an important role in
regulating certain reproductive functions such as endometrial, cervical and
myometrial activity (Telfer, 1995), embryo implantation (Battaglia, 2003) as
well as embryo development (Chwalisz, 1999). While it is apparent from these
studies that NO plays key roles in early pregnancy and even parturition, its
concentration must be tightly regulated as it has also been reported that aberrant
NO levels have been associated with embryo cytotoxicity (Barroso, 1999), early
embryo loss (Haddad, 1995), as well as preterm labor (Cella, 2010). Given that
progesterone has been shown to have an anti-inflammatory effect, it seems
logical to assume that it also plays a major role in the regulation of appropriate
NO concentration during pregnancy. Indeed, the protective role of progesterone
has been shown by modulating the innate immune response in an animal model
of early pregnancy loss induced by inflammation (Aisemberg, 2013; Wolfson,
2013). In fact it was demonstrated that the Intraperitoneal administration
of lipopolysaccharide (LPS), a component of the cell walls of Gram-negative
bacteria, to pregnant mice, induces infiltration of the decidua with granulocytes
and large granular lymphocytes (LGL), increased uterine and decidual
production of nitric oxide (NO) and these changes leads to a 100% of embryonic
resorption and fetal expulsion (Ogando, 2003).
On the other hands, TNFα, is a cell signaling protein (cytokine)
involved in systemic inflammation and is one of the cytokines that make up
the acute phase reaction. It is produced primarily by activated macrophages,
although it is also produced by many other cell types such as CD4+ lymphocytes,
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natural killer cells, neutrophils, mast cells, eosinophils, as well as neurons
(Carswell EA, 1975). The primary role of TNF is in the regulation of immune
cells. Being an endogenous pyrogen, TNF is able to induce fever, apoptotic cell
death, cachexia, inflammation and to inhibit tumorigenesis and viral replication
and respond to sepsis via IL1 & IL6 producing cells. Dysregulation of TNF
production has been implicated in a variety of human diseases including
Alzheimer's disease (Swardfager W, 2010), cancer (Locksley RM, 2001), and
major depression (Dowlati Y, 2010) to name a few. From a reproductive
standpoint, TNF has been identified in the ovary, oviduct, uterus, and placenta
(Terranova PF, 1995), and it is expressed in embryonic tissues (Kohchi C, 1994)
practically at all stages of development. TNFα levels have also been shown to be
significantly elevated in the amniotic fluid of women with uterine infections, and
its increased production correlates with the incidence of preterm labor (Romero
R, 1989). These observations have implicated TNFα as a cytokine involved in
triggering immunological pregnancy loss (Clark DA, 1999; R, 2001), i.e. death
of embryos owing to failure of defense mechanisms preventing rejection of the
semiallogeneic fetoplacental unit.
Materials and Methods
Cell Culture
RAW 264.7 cells were maintained in MEM culture medium (Fisher
Scientific) containing 10% Fetal Calf Serum (FCS, Atlanta Biologicals), 1000 IU
Penicillin/Streptomycin (Sigma Chemicals), 2 mM glutamine (Sigma) at 37oC,
5% CO2. Prior to stimulation assay, RAW cells were cultured to 80% confluence
and harvested by gentle agitation utilizing a 10 mm cell scraper (Fisher). Scraped
cells were then pooled in 1X PBS, and washed twice with centrifugation, 1,800
rpm, 5 min. In between the 2nd and 3rd wash cycle, cell viability assays were
performed to determine living vs. dead cells. With each cell harvest, an aliquot
of RAW cells were returned to culture flasks to maintain the cell line; after
15 passages, cells were discarded as it has been demonstrated that there is a
reduction in receptor expression beyond this time.
Cell Stimulation
Cells were prepared for stimulation assays by combining live cells at
a density of 75 x 103 live cells/ml in Minimal Essential Media (MEM, Fisher)
https://digitalcommons.georgiasouthern.edu/stem_proceedings/vol1/iss1/8
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supplemented with 10% FCS in polystyrene tubes. To appropriate tubes,
lipopolysaccharide (Sigma) was added to final concentrations of 200, 20 or 2 ng
LPS/ml to each tube. One milliliter of each cell suspension was then seeded in
triplicate to 24-well Falcon tissue culture plates (Fisher) and incubated at 37oC,
5% CO2. Each well contained a final concentration of 75 x 103 cells in MEM/
FCS, and the appropriate dilutions of LPS in a final volume of 1 ml. Control wells
contained MEM/FCS alone. Cells were maintained for 48 hrs., afterwhich growth
media was harvested and maintained at -20oC until such time as NO assays were
performed.
To determine the effects of the progesterone receptor on NO and TNF
production, RAW cells were handled and stimulated with LPS as above with the
exception that in appropriate wells, cells were incubated simultaneously in 10
M RU-486 – a selective P4 receptor antagonist. Upon the completion of the 48
hr. incubation period, cell supernatant was handled and NO assays performed as
previously described.
Nitric Oxide Assay.
This protocol was adopted with modifications from that of Griess
(Griess, 1879). Briefly, 100 l aliquots of samples from the cell stimulation assays
above were loaded in triplicate into appropriate wells of a 96-well Corning Costar
ELISA plate (Fisher), followed by 10 l of nitrate reductase solution to each well.
Plates were then incubated at 37oC, 5% CO2 for one hour. After incubation, 80
ml Griess reagent was added to each well and nitrites (NO2-) read at 540 nm on
a plate reader (BioTek). An 8-point sodium nitrate standard was also established
to determine the nitrate concentration of the unknowns.
Tumor Necrosis Factor ELISA (Mouse TNF ELISA Ready-Set-Go, 		
Affymetrix, eBioscience, San Diego, CA).
Initially wells from 96-well Corning Costar (Nunc) plates were coated
with capture antibody (anti-mouse TNF,) in coating buffer and incubating
overnight at 4oC. Plates were then washed 3 times with 250 l/well wash buffer
consisting of 1x phosphate buffered saline (PBS) containing 0.05% Tween-20.
Wells were then subsequently blocked with 200l/well 1x ELISA ELISPOT buffer
at room temperature for 1 hour and all wells washed as previously described.
TNF standards consisting of eight serial dilutions of mouse TNF were then
prepared and 100 l/well of standards were added to corresponding wells.
Additionally, 100 l of media from stimulated cells were added to appropriate
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wells with two additional wells containing ELISA/ELISPOT buffer which served
as plate blanks. Plate was sealed and incubated for 2 hrs. at RT, afterwhich wells
were washed as previously described. The detection antibody (Anti-mouse
TNF-Biotin) in buffer was added at 100l/well. Plate was sealed and incubated
at RT, for an additional 1 hr. and wells washed as previously described. 100
l/well of Avidin-Horseradish Peroxidase (HRP) in buffer was then added to
corresponding wells, and plate was sealed and allowed to incubate for 1 hr at RT,
and wells were washed as previously described. TMB solution was then added at
100 l/well and incubated at RT, 15 min. afterwhich 50 l of stop solution (1M
H2PO4) as added and plates were read at 450 nm on a plate reader (BioTek)
Results
Nitric Oxide Production as a Result of Endotoxin Challenge
Initially, after endotoxin challenge, there was a significant increase (p
< 0.05) in NO production at all concentrations as compared to controls (Fig. 1,
Table 1). Specifically, there was an approximate 40% increase in NO release from
RAW cells with each 10-fold increase in endotoxin concentration (2 ng/ml, 20
ng/ml, 200 ng/well). Upon addition of a saturating concentration of progesterone
(10 M), there was a significant decrease (p < 0.05) in NO production by 12,
46 and 62% at 2, 20 and 200 ng/ml, respectively. To determine if this effect was
due to activation of the progesterone receptor specifically, the P4-R antagonist
RU-486 was co-incubated in wells containing stimulated cells along with
progesterone. In these wells, there was a rebound in NO production – which is
to say a reversal of the inhibitory effect – in cells incubated with 10 M RU-486
by 7, 27 and 58%; while there was a significant difference (p < 0.05) in the cells
stimulated with 20 and 200 ng/well LPS, cells stimulated with 2 ng/ml endotoxin
did not surpass this level of statistical scrutiny.

Figure 1. Effect of Progesterone (P4) on Nitric Oxide (NO) Production. RAW
cells were treated with a 10-fold increase in LPS to stimulate a significant (p <
0.05) concentration-dependent production of NO (blue bars). Treatment of cells
in conjunction with 10 M P4 elicited a significant inhibition of NO production
(red bars). Treatment of cells with 10 M RU-486 – a potent antagonist of P4
https://digitalcommons.georgiasouthern.edu/stem_proceedings/vol1/iss1/8
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exhibited a partial reversal of this inhibitory effect (green bars). * denotes a
significant difference to LPS stimulated cells at that concentration, and ** denotes
a significant difference from LPS stimulated cells and LPS + P4 stimulated cells.

Tumor Necrosis Factor-Alpha Production as a Result of Endotoxin Challenge
Stimulation of RAW 264.7 cells with 2, 20 and 200 ng LPS resulted in a
significant (p < 0.05) concentration-dependent increase in TNF production
as compared to controls (Fig. 2, Table 1). Specifically an approximate 35%
increase in TNFupon stimulation with 2 ng/ml LPS as compared to controls,
followed by a 70% increase in TNF production with two successive 2-fold
increases of LPS concentrations. Upon co-incubation with 10 M P4, there was
a significant (p < 0.05) decrease in TNF production by approximately 70%
at all concentrations of LPS. After inclusion of 10 M RU-486 along with the
saturating concentration of P4, a similar reversal of the inhibitory effect of P4
alone was seen as was observed in the NO assays. While no significant difference
was seen at the low concentration of LPS (2 ng/ml), there was significance at the
two higher concentrations (20, 200 ng/ml).
Published
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Figure 2. Effect of Progesterone (P4) on Tumor Necrosis Factor-Alpha
Production. RAW cells were treated with a 10-fold increase in LPS to stimulate a
significant (p < 0.05) concentration-dependent production of TNF (blue bars).
Treatment of cells in conjunction with 10 M P4 elicited a significant inhibition
of NO production (red bars). Treatment of cells with 10 M RU-486 – a potent
antagonist of P4 exhibited a partial reversal of this inhibitory effect (green bars).
* denotes a significant difference to LPS stimulated cells at that concentration,
and ** denotes a significant difference from LPS stimulated cells and LPS + P4
stimulated cells.

Discussion
These data clearly indicate that stimulation of RAW 264.7 cells with varying
concentrations of lipopolysaccharide (LPS) initiate an inflammatory response
insofar as the production of nitric oxide (NO) and tumor necrosis factor-alpha
(TNF) are concerned. These results are to be expected however as RAW cells
are an immortalized murine macrophage leukemic cell line established from an
ascites of a tumor induced in a male mouse (Mus musculus) by intraperitoneal
https://digitalcommons.georgiasouthern.edu/stem_proceedings/vol1/iss1/8
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injection of Abselon Leukaemia Virus (A-MuLV) (Raschke WC, 1978). RAW
cells were chosen as the experimental model in the present study as they
propagate quickly, cell culture needs are minimal - but more importantly - upon
stimulation with an inflammatory insult results in a myriad of immunologic
responses. In the present study, we were able to show that RAW 264.7 cells
express the progesterone receptor, and that progesterone binds with high affinity
and saturation at 125 nm (Fig. 3).
Figure 3. P4-FITC Binding Assay. RAW 264.7 cells were treated with 2-fold serial
dilutions of FITC-P4 in Ros media and incubated, 1 hr. 100 l of cell-P4-FITC
solution was then added to 300 l FACS buffer and incubated an additional hr.
Cell suspension was then washed 3x followed by analysis on an Accuri C6 Plus
flow cytometer (Becton-Dickinson).

Further, stimulation of RAW cells with LPS initiates an inflammatory response
by the production of NO and TNF in a concentration dependent manner.
Additionally, we were able to show that upon co-incubation with progesterone
this response was ameliorated as shown by the reduction in both inflammatory
mediators. That being said, because we have demonstrated this response, it
should not be assumed that this response is due to the effects of progesterone
acting solely through its receptor. In fact, in a rather elegant study by Wolfson
and colleagues (Wolfson ML, 2016), it was shown that in a rat model, stimulation
with endotoxin resulted in a significant increase in NO production, and that this
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effect was inhibited by treatment with progesterone as seen in the current study.
However, it was also reported in this study that this response was independent
of progesterone receptor activation as co-treatment with a progesterone receptor
antagonist had no apparent effect on this inhibitory effect (Wolfson ML, 2016).
These authors went further to suggest that perhaps this response was an effect of
glucocorticoid receptors activation as incubation of cells with a glucocorticoid
receptor antagonist restored similar NO levels as was seen in cells stimulated
with LPS alone. In the present study, we show that in fact the progesterone
receptor activation is involved by a partial reversal of progesterone’s inhibitory
activity of both NO and TNF (Fig’s. 1, 2; Table 1).
Table 1. Production of nitric oxide and tumor necrosis factor from LPSchallenged RAW 264.7 cells, and subsequent P4-dependent inhibition. Nitric
oxide assays revealed a concentration-dependent increase in NO production
followed by a 12, 46 and 62% inhibition following P4 incubation. Tumor necrosis
factor assays revealed a similar concentration-dependent increase in cytokine
production followed by a 71, 76 and 75% inhibition of TNF following P4
incubation. With the exception of the low dose of LPS in the NO assays, RU-486
revealed a partial reversal of this inhibitory effect.
NO Production in LPS-Challenged RAW 264.7 Cells
LPS (ng) NO (pg)
NO Gain
P4 Inhibition Antagonism RU-486
2
17.3
20.09%
12.05%
NA
20 28.25
48.78%
46.21%
26.56%
200 47.54
64.48%
61.71%
58.13%
TNFα Production in LPS-Challenged RAW 264.7 Cells
LPS (ng) TNFα (pg) TNFα Gain P4 Inhibition Antagonism RU-486
2 51.11
37.52%
70.71%
55.56%
20 178.89
64.86%
76.09%
74.12%
200 642.11
81.32%
75.26%
69.84%

pecifically, regarding the production of these two inflammatory mediators, a
58.13% and 69.84% increase in NO and TNFwas observed, respectively from
cells stimulated with 200 ng LPS (high dose). With this in mind, the question
arises as to why the contrasting effects in this study as compared to that reported
by Wolfson et al. To this point, the answer may lie in the fact that the study by
Wolfson was conducted through the in vivo infusion of LPS to pregnant and
https://digitalcommons.georgiasouthern.edu/stem_proceedings/vol1/iss1/8
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non-pregnant mice with or without progesterone and two differing antagonist –
RU-486 and Lonaprisan – a P4 antagonist with higher affinity for the P4-R than
RU-486. Peripheral blood monocytes (PBMC) were then collected, cultured
for 24 hrs afterwhich cell supernatants assayed for nitrates and nitrites as
described. Additionally, PBMC from these mice were also assayed for inducible
nitric oxide synthase (iNOS) mRNA as an indicator of NO production. In the
present study, our group directly stimulated RAW 264.7 cells (a macrophage cell
line) with a range of LPS concentrations as well as fixed concentrations of both
progesterone and RU-486. Given this, it is difficult to compare the two studies
due to the fact that in the report by Wolfson et al., LPS (1 g/g), progesterone
(67 g/g – pregnant mice and 4g/g – non-pregnant mice), RU-486 (10g/g)
and Lonaprisan (1 g/g) were administered via intraperitoneal injection while
in the present study, RAW cells were stimulated with LPS (2, 20 and 200 ng/
ml), and further treated with progesterone (10 M) and RU-486 (10 M) at
fixed concentrations. Irrespective of these discrepancies, it seems clear that
1) progesterone plays a centralized role in the maintenance of pregnancy and
regulation of NO and TNF concentrations in reproductive tissues and, based on
these results, that 2) it is an important inhibitory mediator in the inflammatory
response insofar as NO and TNF production are concerned, and 3) the action of
which are at least in part, through activation of the progesterone receptor.
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